Ampio Pharmaceutical's FDA application for Ampion clinical study to treat COVID-19 ARDS on TV

Ampio Pharmaceutical's FDA application for Ampion clinical study to treat COVID-19 ARDS on TV

ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE American: AMPE) announced it was featured on aFOXTV segment titled, "Englewoodpharmaceutical company looking to treat COVID-19 patients with... Read More

Friday April 3, 2020 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, Michael Macaluso, FDA, COVID-19, ARDS

Aytu BioScience gets FDA approval to begin distribution of COVID-19 rapid tests across U.S.

Aytu BioScience gets FDA approval to begin distribution of COVID-19 rapid tests across U.S.

ENGLEWOOD -- Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced it has received... Read More

Thursday March 26, 2020 0 comments Tags: Englewood, Aytu BioScience, John Disbrow, COVID-19

Ampio prepares FDA protocol to study Ampion as treatment for COVID-19 Acute Respiratory Distress

Ampio prepares FDA protocol to study Ampion as treatment for COVID-19 Acute Respiratory Distress

ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE American: AMPE) announced it is preparing an expanded access FDA protocolto study potential benefit of nebulized treatment with Ampion in SARS-Cov-2... Read More

Wednesday March 25, 2020 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, COVID-19

Partnership boosts angel investment in Denver South community

Partnership boosts angel investment in Denver South community

ENGLEWOOD -- Rockies Venture Club (RVC) was recently awarded $470,000 by the Colorado Office of Economic Development and International Trade (OEDIT) to establish new angel investing communities... Read More

Thursday March 5, 2020 0 comments Tags: Englewood, Rockies Venture Club, Eric Byington, Denver South EDP

Zynex receives FDA clearance for blood volume monitor

Zynex receives FDA clearance for blood volume monitor

ENGLEWOOD -- Zynex, Inc. (NASDAQ: ZYXI) today announced the U.S. Food and Drug Administration granted 510(k) clearance for sale in the U.S. of the companys CM-1500 Blood Volume Monitor. Zynex is... Read More

Wednesday February 26, 2020 0 comments Tags: Englewood, Zynex, Thomas Sandgaard

Paragon 28 launches TenoTac Soft Tissue Fixation System

Paragon 28 launches TenoTac Soft Tissue Fixation System

ENGLEWOOD -- Paragon 28 announced the launch of the TenoTac Soft Tissue Fixation System, providing surgeons the first and only dedicated system to address tendon transfers of the forefoot to... Read More

Monday February 24, 2020 0 comments Tags: Englewood, Paragon 28, TenoTac Soft Tissue Fixation System

Paragon 28 announces launch of Phantom Hindfoot repair system

Paragon 28 announces launch of Phantom Hindfoot repair system

ENGLEWOOD -- Paragon 28 announced the launch of the Phantom Hindfoot TTC/TC System to address tibiotalocalcaneal (TTC) and tibiocalcaneal (TC) arthrodesis. The Phantom Hindfoot TTC/TC System... Read More

Wednesday February 19, 2020 0 comments Tags: Englewood, Paragon 28, Phantom Hindfoot

Paragon 28's Paratrooper Plantar Plate Repair System receives FDA 510(k) clearance

Paragon 28's Paratrooper Plantar Plate Repair System receives FDA 510(k) clearance

ENGLEWOOD -- Paragon 28 announced its Paratrooper Plantar Plate Repair System , developed to allow surgeons to use a dorsal or plantar approach to the plantar plate repair procedure using a... Read More

Monday February 10, 2020 0 comments Tags: Englewood, Paragon 28, Paratrooper Plantar Plate System